Keyphrases
Microbicides
100%
Explant Culture
50%
UC781
39%
Genital
33%
HIV Patients
33%
Inflammatory Effects
33%
Herpes Simplex Virus
33%
Human Explants
20%
Naphthalene Sulfonates
20%
Combination Evaluation
20%
Amphiphilic Polymer
20%
Virucidal Agent
20%
Independent Candidates
20%
Nucleoside Analogues
16%
Iterative Approach
16%
Human Trials
16%
Combination Therapy
16%
Mucosal Inflammation
16%
Clinical Trials
16%
Topical Agents
16%
Sexually Transmitted Pathogens
16%
Reverse Transcription
16%
Clinical Experience
16%
Rectal Administration
16%
Genital Tract
16%
Evade
16%
Bile Salts
16%
Virus
16%
Viral Glycoprotein
16%
Best Combination
16%
Enhanced Efficacy
16%
Optimal Combination
16%
Rational Development
16%
Topical Microbicides
16%
Cell Entry
16%
Outcome Prediction
16%
Primary Cell Culture
16%
Immunological Effects
16%
Preclinical Development
16%
Culture System
16%
Phase I Clinical Trial
16%
Virologic
16%
Vaginal Gel
16%
Pilot Randomized Controlled Trial
16%
HIV Life Cycle
16%
HIV Infection
16%
Cell Culture
16%
Infection Model
16%
Preclinical Evaluation
16%
Mucosal Immunity
16%
Activity Effect
16%
Herpes Simplex Virus 2 (HSV-2)
16%
Spectrum of Activity
16%
Gel Formulation
16%
In Vitro Study
16%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
16%
Antiviral Activity
16%
Dual Infection
16%
Clinical Evaluation
16%
Viral Entry
16%
Combined Antiretroviral Therapy (cART)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Microbicide
100%
HIV
100%
Clinical Trial
44%
N [4 Chloro 3 (3 Methyl 2 Butenyloxy)phenyl] 2 Methyl 3 Furancarbothioamide
26%
Tenofovir
22%
Herpes Simplex Virus
22%
Infection
11%
Nonnucleoside Reverse Transcriptase Inhibitor
11%
Sulfonic Acid
11%
Naphthalene
11%
Glycoprotein
11%
Human Immunodeficiency Virus Infection
11%
Topical Agent
11%
Antiviral Activity
11%
Antivirus Agent
11%
Inflammation
11%
Infectious Agent
11%
Combination Therapy
11%
Herpes Simplex Virus 2
11%
Bile Salt
11%
Rectal Administration
11%
Clinical Study
11%